RXO FY 2023: revenue $3.9B, down 18%; diluted EPS $0.03

Key figures from this report

These are the numbers RXO reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$3.9B−18% from $4.8B in FY 202210-K income statement, on EDGAR
2. Net income$4.0M−96% from $92.0M in FY 202210-K income statement, on EDGAR
3. Diluted EPS$0.03−96% from $0.79 in FY 202210-K income statement, on EDGAR
4. Cash and cash equivalents$5.0M−95% from $98.0M in FY 202210-K balance sheet, on EDGAR
5. Cash from operations$89.0M−71% from $310.0M in FY 202210-K cash flow statement, on EDGAR

Every year in the financial tables